32100783|t|Conjugation of RTHLVFFARK to human lysozyme creates a potent multifunctional modulator for Cu2+-mediated amyloid beta-protein aggregation and cytotoxicity.
32100783|a|Amyloid beta-peptide (Abeta) aggregation induced by metal ions such as Cu2+ has been recognized as a crucial step in the pathogenesis of Alzheimer's disease (AD), so development of multifunctional agents that are able to inhibit Abeta aggregation and modulate Cu2+-Abeta species is considered as a promising strategy for fighting against AD. Our recent work proved that basification of human lysozyme (hLys) is in favor of enhancing the inhibition of Abeta aggregation. Based on the finding, we have herein designed R-hLys, a conjugate of bifunctional alkaline decapeptide (RTHLVFFARK, RK10) coupled onto hLys via reaction with the carboxyl groups on hLys. The design created an even more basic protein than hLys, thus increasing the potency of hLys on inhibiting Abeta fibrillation. Moreover, the RK10 conjugation onto hLys introduced a specific Cu2+-chelator and an additional peptide inhibitor (LVFFARK). Thus, a multifunctional modulator on Cu2+-mediated Abeta aggregation and cytotoxicity was developed. The multifunctional effects of R-hLys were systematically investigated on Abeta aggregation, Cu2+-mediated Abeta aggregation, ROS production, and remodeling mature Abeta species by comparison to its counterparts. The results revealed the following: (1) R-hLys possesses high potency on inhibiting Abeta fibrillogenesis; R-hLys at 1/5 to 1/4 of hLys concentration works similarly to hLys. (2) R-hLys exhibits high performance on inhibiting Cu2+-induced Abeta aggregation and cytotoxicity; it increased the cell viability from 48.9% to 86.1% at an equimolar concentration to Abeta. (3) R-hLys arrests the production of reactive oxygen species catalyzed by Cu2+ or Cu2+-Abeta42 species. (4) R-hLys remodels mature Abeta42 fibrils and Cu2+-Abeta42 aggregates into small amorphous aggregates of lower cytotoxicity; by co-incubation with R-hLys, the cytotoxicities of mature Abeta42 fibrils and Cu2+-Abeta42 aggregates are reduced from 31.4% to 14.2% and 48.1% to 10.4%, respectively. Taken together, R-hLys is a potent multifunctional modulator for inhibiting Abeta/Cu2+-mediated-Abeta aggregation, suppressing ROS production and remodeling mature Abeta42/Cu2+-Abeta42 species.
32100783	29	34	human	Species	9606
32100783	35	43	lysozyme	Gene	4069
32100783	91	95	Cu2+	Chemical	-
32100783	142	154	cytotoxicity	Disease	MESH:D064420
32100783	178	183	Abeta	Gene	351
32100783	208	213	metal	Chemical	MESH:D008670
32100783	227	231	Cu2+	Chemical	-
32100783	293	312	Alzheimer's disease	Disease	MESH:D000544
32100783	314	316	AD	Disease	MESH:D000544
32100783	385	390	Abeta	Gene	351
32100783	416	420	Cu2+	Chemical	-
32100783	421	426	Abeta	Gene	351
32100783	494	496	AD	Disease	MESH:D000544
32100783	542	547	human	Species	9606
32100783	548	556	lysozyme	Gene	4069
32100783	607	612	Abeta	Gene	351
32100783	672	678	R-hLys	Chemical	-
32100783	708	728	alkaline decapeptide	Chemical	-
32100783	730	740	RTHLVFFARK	Chemical	-
32100783	742	746	RK10	Chemical	-
32100783	920	925	Abeta	Gene	351
32100783	954	958	RK10	Chemical	-
32100783	1003	1007	Cu2+	Chemical	-
32100783	1054	1061	LVFFARK	Chemical	-
32100783	1101	1105	Cu2+	Chemical	-
32100783	1115	1120	Abeta	Gene	351
32100783	1137	1149	cytotoxicity	Disease	MESH:D064420
32100783	1239	1244	Abeta	Gene	351
32100783	1258	1262	Cu2+	Chemical	-
32100783	1272	1277	Abeta	Gene	351
32100783	1291	1294	ROS	Chemical	MESH:D017382
32100783	1329	1334	Abeta	Gene	351
32100783	1418	1424	R-hLys	Chemical	-
32100783	1462	1467	Abeta	Gene	351
32100783	1485	1491	R-hLys	Chemical	-
32100783	1557	1563	R-hLys	Chemical	-
32100783	1604	1608	Cu2+	Chemical	-
32100783	1617	1622	Abeta	Gene	351
32100783	1639	1651	cytotoxicity	Disease	MESH:D064420
32100783	1738	1743	Abeta	Gene	351
32100783	1782	1805	reactive oxygen species	Chemical	MESH:D017382
32100783	1819	1823	Cu2+	Chemical	-
32100783	1827	1831	Cu2+	Chemical	-
32100783	1832	1839	Abeta42	Gene	351
32100783	1853	1859	R-hLys	Chemical	-
32100783	1876	1883	Abeta42	Gene	351
32100783	1896	1900	Cu2+	Chemical	-
32100783	1901	1908	Abeta42	Gene	351
32100783	1961	1973	cytotoxicity	Disease	MESH:D064420
32100783	1997	2003	R-hLys	Chemical	-
32100783	2034	2041	Abeta42	Gene	351
32100783	2054	2058	Cu2+	Chemical	-
32100783	2059	2066	Abeta42	Gene	351
32100783	2220	2225	Abeta	Gene	351
32100783	2226	2230	Cu2+	Chemical	-
32100783	2240	2245	Abeta	Gene	351
32100783	2271	2274	ROS	Chemical	MESH:D017382
32100783	2308	2315	Abeta42	Gene	351
32100783	2316	2320	Cu2+	Chemical	-
32100783	2321	2328	Abeta42	Gene	351
32100783	Association	MESH:D000544	351
32100783	Association	MESH:D064420	4069
32100783	Negative_Correlation	351	4069

